Loss of motor function in preclinical Alzheimer's disease

Expert Review of Neurotherapeutics

Volumn 11, Issue 5, 2011, Pages 665-676

  Buchman, Aron S ^a,b   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; cognitive decline; dementia; mild cognitive impairment; motor decline; preclinical AD

Indexed keywords

ALZHEIMER DISEASE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; GENETIC POLYMORPHISM; HUMAN; MILD COGNITIVE IMPAIRMENT; MORTALITY; MOTOR PERFORMANCE; MUSCLE STRENGTH; OLFACTORY DISCRIMINATION; PARKINSONISM; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY;

AGING; ALZHEIMER DISEASE; COGNITION; COHORT STUDIES; DEMENTIA; HUMANS; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS;

EID: 79955660818     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.57     Document Type: Review

References (161)

1. Bennett DA. Part II. Clinical diagnosis and course of Alzheimer's disease. Dis. Mon. 46(10), 666-687 (2000).
2. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7), 939-944 (1984). (Pubitemid 14076461)
3. Bennett DA, Schneider JA, Aggarwal NT et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27(3), 169-176 (2006). (Pubitemid 44651437)
4. Arnold SE. Part III. Neuropathology of Alzheimer's disease. Dis. Mon. 46(10), 687-705 (2000).
5. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 41(4), 479-479 (1991).
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82(4), 239-259 (1991).
7. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging 18(4 Suppl.), S1-S2 (1997).
8. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch. Neurol. 42(11), 1097-1105 (1985). (Pubitemid 16236926)
9. Rentz DM, Locascio JJ, Becker JA et al. Cognition, reserve, and amyloid deposition in normal aging. Ann. Neurol. 67(3), 353-364 (2010).
10. Sperling RA, Laviolette PS, O'Keefe K et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63(2), 178-188 (2009).
11. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 7(2), 331-356 (1968).
12. Katzman R, Terry R, Deteresa R et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23(2), 138-144 (1988). (Pubitemid 18081451)
13. Crystal HA, Dickson DW, Sliwinski MJ et al. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol. 34(4), 566-573 (1993). (Pubitemid 23289408)
14. Morris JC, Storandt M, Mckeel DW Jr. et al. Cerebral amyloid deposition and diffuse plaques in 'normal' aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46(3), 707-719 (1996).
15. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, Mcintyre LM. Neuropathological and neuropsychological changes in 'normal' aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 57(12), 1168-1174 (1998). (Pubitemid 28562746)
16. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol. 58(4), 376-388 (1999). (Pubitemid 29187900)
17. Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Grip strength and the risk of incident Alzheimer's disease. Neuroepidemiology 29(1-2), 66-73 (2007). (Pubitemid 350191420)
18. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Ann. NY Acad. Sci. 1170, 730-735 (2009).
19. Wilson RS, Barnes LL, Mendes de Leon CF et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 59(3), 364-370 (2002). (Pubitemid 34857928)
20. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 65(6), 892-897 (2005). (Pubitemid 41362136)
21. Hikosaka O, Nakamura K, Sakai K, Nakahara H. Central mechanisms of motor skill learning. Curr. Opin. Neurobiol. 12(2), 217-222 (2002). (Pubitemid 34518343)
22. Burke RE. Some unresolved issues in motor unit research. Adv. Exp. Med. Biol. 508, 171-178 (2002). (Pubitemid 34953740)
23. Burke RE (Ed.). Motor Units: Anatomy, Physiology and Functional Organization. American Physiological Society, DC, USA (1981).
24. Jeannerod M, Arbib MA, Rizzolatti G, Sakata H. Grasping objects: The cortical mechanisms of visuomotor transformation. Trends Neurosci. 18, 314-320 (1995).
25. Fogassi L, Luppino G. Motor functions of the parietal lobe. Curr. Opin. Neurobiology 15(6), 626-631 (2005). (Pubitemid 41682302)
26. Fogassi L, Ferrari PF, Gesierich B, Rozzi S, Chersi F, Rizzolatti G. Parietal lobe: From action organization to intention understanding. Science 308(5722), 662-667 (2005). (Pubitemid 40594381)
27. Rizzolatti G, Luppino G. The cortical motor system. Neuron 31(6), 889-901 (2001). (Pubitemid 32925277)
28. Halsband U, Lange RK. Motor learning in man: A review of functional and clinical studies. J. Physiol. Paris 99(4-6), 414-424 (2006). (Pubitemid 43850801)
29. Lehericy S, Bardinet E, Tremblay L et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb. Cortex 16(2), 149-161 (2006). (Pubitemid 43100060)
30. Poppele R, Bosco G. Sophisticated spinal contributions to motor control. Trends Neurosci. 26, 269-276 (2003). (Pubitemid 36556158)
31. Bizzi E, D'Avella A, Saltiel P, Tresch M. Modular organization of spinal motor systems. Neuroscientist 8(5), 437-442 (2002).
32. Gosgnach S, Lanuza GM, Butt SJB et al. V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature 440(7081), 215-219 (2006). (Pubitemid 43372099)
33. Lanuza GM, Gosgnach S, Pierani A, Jessell TM, Goulding M. Genetic identification of spinal interneurons that coordinate left-right locomotor activity necessary for walking movements. Neuron 42(3), 375-373 (2004).
34. Gordon IT, Whelan PJ. Deciphering the organization and modulation of spinal locomotor central pattern generators. J. Exp. Biol. 209(11), 2007-2014 (2006). (Pubitemid 43987877)
35. Buford TW, Anton SD, Judge AR et al. Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res. Rev. 9(4), 369-383 (2010).
36. Buford TW, Cooke MB, Manini TM, Leeuwenburgh C, Willoughby DS. Effects of age and sedentary lifestyle on skeletal muscle NF-kB signaling in men. J. Gerontol. A Biol. Sci. Med. Sci. 65A(5), 532-537 (2010).
37. Zaehle T, Jordan K, Wüstenberg T, Baudewig J, Dechent P, Mast FW. The neural basis of the egocentric and allocentric spatial frame of reference. Brain Res. 1137, 92-103 (2007). (Pubitemid 46240050)
38. Bakker M, De Lange FP, Helmich RC, Scheeringa R, Bloem BR, Toni I. Cerebral correlates of motor imagery of normal and precision gait. Neuroimage 41(3), 998-1010 (2008).
39. Rosano C, Aizenstein HJ, Studenski S, Newman AB. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J. Gerontol. A Biol. Sci. Med. Sci. 62(9), 1048-1055 (2007). (Pubitemid 47531224)
40. Rosano C, Brach J, Longstreth Jr WT, Newman AB. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology 26(1), 52-60 (2006). (Pubitemid 41797938)
41. Rosano C, Brach J, Studenski S, Longstreth WT Jr, Newman AB. Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology 29(3-4), 193-200 (2007). (Pubitemid 351197522)
42. Buchman AS, Wilson RS, Bienias JL, Bennett DA. Change in frailty and risk of death in older persons. Exp. Aging Res. 35(1), 61-82 (2009).
43. Delmonico MJ, Harris TB, Lee J-S et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J. Am. Geriatr. Soc. 55(5), 769-774 (2007). (Pubitemid 46668965)
44. Louis ED, Schupf N, Marder K, Tang MX. Functional correlates of mild parkinsonian signs in the community-dwelling elderly: Poor balance and inability to ambulate independently. Mov. Disord. 21(3), 411-416 (2006).
45. Onder G, Penninx BW, Ferrucci L, Fried LP, Guralnik JM, Pahor M. Measures of physical performance and risk for progressive and catastrophic disability: Results from the Women's Health and Aging Study. J. Gerontol. A Biol. Sci. Med. Sci. 60(1), 74-79 (2005). (Pubitemid 40326255)
46. Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch. Neurol. 62(2), 297-302 (2005). (Pubitemid 40204752)
47. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 59(3), 255-263 (2004). (Pubitemid 38375339)
48. Louis ED, Bennett DA. Mild parkinsonian signs: An overview of an emerging concept. Mov. Disord. 22(12), 1681-1688 (2007). (Pubitemid 47597591)
49. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147(8), 755-763 (1998). (Pubitemid 28183275)
50. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: Evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56(3), M146-M156 (2001). (Pubitemid 32187141)
51. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 64(7), 1157-1161 (2005).
52. Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Change in motor function and risk of mortality in older persons. J. Am. Geriatr. Soc. 55(1), 11-19 (2007). (Pubitemid 46046223)
53. Buchman AS, Leurgans SE, Boyle PA, Schneider JA, Arnold SE, Bennett DA. Combinations of motor measures more strongly predict adverse health outcomes in old age: The Rush Memory and Aging Project, a community-based cohort study. BMC Med. (2011) (In press).
54. Chainay H, Louarn C, Humphreys GW. Ideational action impairments in Alzheimer's disease. Brain Cogn. 62(3), 198-205 (2006). (Pubitemid 46075072)
55. Derouesné C, Lagha-Pierucci S, Thibault S, Baudouin-Madec V, Lacomblez L. Apraxic disturbances in patients with mild to moderate Alzheimer's disease. Neuropsychologia 38(13), 1760-1769 (2000).
56. Della Sala S, Spinnler H, Venneri A. Walking difficulties in patients with Alzheimer's disease might originate from gait apraxia. J. Neurol. Neurosurg. Psychiatry 75(2), 196-201 (2004). (Pubitemid 38183523)
57. Hebert LE, Bienias JL, Mccann JJ, Scherr PA, Wilson RS, Evans DA. Upper and lower extremity motor performance and functional impairment in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 25(5), 425-431 (2010).
58. Agosta F, Rocca MA, Pagani E et al. Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. Hum. Brain Mapp. 31(4), 515-525 (2010).
59. Babiloni C, Frisoni GB, Vecchio F et al. Stability of clinical condition in mild cognitive impairment is related to cortical sources of a rhythms: An electroencephalographic study. Hum. Brain Mapp. DOI: 10.1002/hbm.21157 (2010) (Epub ahead of print).
60. Jahng G-H, Xu S, Weiner M, Meyerhoff D, Park S, Schuff N. DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients. Neuroradiology 1-14-14 (2011).
61. Stump CS, Henriksen EJ, Wei Y, Sowers JR. The metabolic syndrome: Role of skeletal muscle metabolism. Ann. Med. 38(6), 389-402 (2006). (Pubitemid 44484877)
62. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: Nine-year follow-up data from the Kungsholmen Project. J. Am. Geriatr. Soc. 56(1), 111-116 (2008).
63. Dahl A, Hassing LB, Fransson E et al. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J. Gerontol. A Biol. Sci. Med. Sci. 65A(1), 57-62 (2010).
64. Ogunniyi A, Gao S, Unverzagt FW et al. Weight loss and incident dementia in elderly Yoruba Nigerians: A 10-year follow-up study. Int. Psychogeriatr. 23(3), 387-394 (2010).
65. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 71(14), 1057-1064 (2008).
66. Stewart R, Masaki K, Xue Q-L et al. A 32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging study. Arch. Neurol. 62(1), 55-60 (2005). (Pubitemid 40105036)
67. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med. 163(13), 1524-1528 (2003). (Pubitemid 36835095)
68. Verdijk LB, Snijders T, Beelen M et al. Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. J. Am. Geriatr. Soc. 58(11), 2069-2075 (2010).
69. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 34(12), 809-824 (2004). (Pubitemid 39452208)
70. Hairi NN, Cumming RG, Naganathan V et al. Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: The concord Health and Ageing in Men Project. J. Am. Geriatr. Soc. 58(11), 2055-2062 (2010).
71. Gustafson D. Adiposity indices and dementia. Lancet Neurol. 5(8), 713-720 (2006). Suggests that that the link between BMI and risk of dementia is more complex and may vary over the lifespan. (Pubitemid 44062421)
72. Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch. Neurol. 66(11), 1339-1344 (2009). Loss of strength is common in old age and this study demonstrated that appendicular and axial muscle strength in older persons is associated with the risk of developing mild cognitive impairment (MCI), Alzheimer's disease (AD) and cognitive decline.
73. Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve 25(1), 17-25 (2002). (Pubitemid 34019730)
74. Camicioli R, Howieson D, Oken B, Sexton G, Kaye J. Motor slowing precedes cognitive impairment in the oldest old. Neurology 50(5), 1496-1498 (1998). (Pubitemid 28240384)
75. Buracchio T, Dodge HH, Howieson D, Wasserman D, Kaye J. The trajectory of gait speed preceding mild cognitive impairment. Arch. Neurol. 67(8), 980-989 (2010). Motor decline, as indexed by gait speed, accelerates up to 12 years before MCI. Thus, the rate of change in motor decline may identify individuals at risk for developing dementia during its preclinical stage.
76. Boyle PA, Wilson RS, Buchman AS et al. Lower extremity motor function and disability in mild cognitive impairment. Exp. Aging Res. 33(3), 355-371 (2007). (Pubitemid 46752292)
77. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch. Neurol. 63(12), 1763-1769 (2006). (Pubitemid 44925086)
78. Watson NL, Rosano C, Boudreau RM et al. Executive function, memory, and gait Speed decline in well-functioning older adults. J. Gerontol. A Biol. Sci. Med. Sci. 65A(10), 1093-1100 (2010).
79. Wang L, Larson EB, Bowen JD, Van Belle G. Performance-based physical function and future dementia in older people. Arch. Intern. Med. 166(10), 1115-1120 (2006). (Pubitemid 43765183)
80. Inzitari M, Newman AB, Yaffe K et al. Gait speed predicts decline in attention and psychomotor speed in older adults: The Health Aging and Body Composition Study. Neuroepidemiology 29, 156-162 (2007). (Pubitemid 351197517)
81. Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J. Neurol. Sci. 229-230, 89-93 (2005). (Pubitemid 40341570)
82. Ble A, Volpato S, Zuliani G et al. Executive function correlates with walking speed in older persons: The InCHIANTI study. J. Am. Geriatr. Soc. 53(3), 410-415 (2005). (Pubitemid 41623518)
83. Soumare A, Tavernier B, Alperovitch A, Tzourio C, Elbaz A. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. J. Gerontol. A Biol. Sci. Med. Sci. 1058-1065 (2009).
84. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch. Neurol. 60(4), 539-544 (2003). (Pubitemid 36427968)
85. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 43(11), 2184-2188 (1993). (Pubitemid 23346944)
86. Portet F, Scarmeas N, Cosentino S, Helzner EP, Stern Y. Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch. Neurol. 66(9), 1120-1126 (2009).
87. Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report. J. Am. Geriatr. Soc. 52(4), 625-634 (2004). (Pubitemid 38480644)
88. Bandeen-Roche K, Xue Q-L, Ferrucci L et al. Phenotype of frailty: Characterization in the women's health and aging studies. J. Gerontol. A Biol. Sci. Med. Sci. 61(3), 262-266 (2006).
89. Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom. Med. 69(5), 483-489 (2007). (Pubitemid 46987892)
90. Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J. Am. Geriatr. Soc. 58(2), 248-255 (2010).
91. Ungvari Z, Kaley G, De Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: New perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65A(10), 1028-1041 (2010).
92. Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84(4), 932-939 (2008).
93. Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10(2), 187-198 (2011).
94. Sultana R, Perluigi M, Butterfield D. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Ab in pathogenesis. Acta Neuropathologica 118(1), 131-150 (2009).
95. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 61(3), 378-384 (2004). (Pubitemid 38327357)
96. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE. Amyloid mediates the association of apolipoprotein E ε4 allele to cognitive function in older people. J. Neurol. Neurosurg. Psychiatry 76(9), 1194-1199 (2005). (Pubitemid 41208366)
97. Mahley RW, Weisgraber KH, Huang Y. Inaugural article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. 103(15), 5644-5651 (2006).
98. Houlden H, Greenwood R. Apolipoprotein ε4 and traumatic brain injury. J. Neurol. Neurosurg. Psychiatry 77(10), 1106-1107 (2006).
99. Wilson RS, Schneider JA, Barnes LL et al. The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 59(7), 1154-1160 (2002). (Pubitemid 34755829)
100. Sudlow C, Martinez Gonzalez NA, Kim J, Clark C. Does Apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage?: Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 37(2), 364-370 (2006). (Pubitemid 43731988)
101. Burt TD, Agan BK, Marconi VC et al. Apolipoprotein (apo) ε4 enhances HIV-1 cell entry in vitro, and the APOE e4/e4 genotype accelerates HIV disease progression. Proc. Natl Acad. Sci. 105(25), 8718-8723 (2008). (Pubitemid 351987746)
102. Buchman AS, Boyle PA, Wilson RS, Beck T, Kelly JF, Bennett DA. Apolipoprotein E ε4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis. Assoc. Disord. 23, 63-69 (2009).
103. Jun G, Naj AC, Beecham GW et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 67(12), 1473-1484 (2010).
104. Seshadri S, Fitzpatrick AL, Ikram MA et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18), 1832-1840 (2010).
105. Claeys KG, Maisonobe T, Böhm J et al. Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation. Neurology 74(6), 519-521 (2010).
106. Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 26(2), 61-67 (2006). (Pubitemid 43201300)
107. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch. Gen. Psychiatry 64(7), 802-808 (2007). (Pubitemid 47026376)
108. Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA. Lewy bodies and olfactory dysfunction in old age. Chem. Senses DOI: 10.1093/chemse/bjq139 (2011) (Epub ahead of print).
109. Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA. Odor identification and progression of parkinsonian signs in older persons. Exp. Aging Res. 34(3), 173-187 (2008). (Pubitemid 351882842)
110. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J. Am. Geriatr. Soc. 56(8), 1517-1521 (2008).
111. Olofsson JK, Ronnlund M, Nordin S, Nyberg L, Nilsson LG, Larsson M. Odor identification deficit as a predictor of five-year global cognitive change: Interactive effects with age and ApoE-e4. Behav. Genet. 39(5), 496-503 (2009).
112. Schrijvers EMC, Witteman JCM, Sijbrands EJG, Hofman A, Koudstaal PJ, Breteler MMB. Insulin metabolism and the risk of Alzheimer disease. Neurology 75(22), 1982-1987 (2010).
113. Rocca WA, Petersen RC, Knopman DS et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Demen. 7(1), 80-93 (2011).
114. Hoffman LB, Schmeidler J, Lesser GT et al. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 72(20), 1720-1726 (2009).
115. Beeri MS, Ravona-Springer R, Silverman JM, Haroutunian V. The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin. Neurosci. 11(2), 201-212 (2009).
116. Arvanitakis Z, Bennett DA, Wilson RS, Barnes LL. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis. Assoc. Disord. 24(1), 37-42 (2009).
117. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61(5), 661-666 (2004). (Pubitemid 38637681)
118. Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29(3), 560-565 (2006). (Pubitemid 44115354)
119. Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. Hypertension and lower walking speed in the elderly: The Three-City study. J. Hypertension 28(7), 1506-1514. (2010).
120. Sorond FA, Galica A, Serrador JM et al. Cerebrovascular hemodynamics, gait, and falls in an elderly population. Neurology 74(20), 1627-1633 (2010).
121. Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA. Diabetes and parkinsonian signs in older persons. Alzheimer Dis. Assoc. Disord. 21(2), 144-149 (2007). (Pubitemid 46878976)
122. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 63(6), 996-1001 (2004). (Pubitemid 39287906)
123. Buchman AS, Boyle PA, Wilson RS, Leurgans S, Shah RC, Bennett DA. Respiratory muscle strength predicts decline in mobility in older persons. Neuroepidemiology 31(3), 174-180 (2008).
124. Buchman AS, Boyle PA, Leurgans SE, Evans DA, Bennett DA. Pulmonary function, muscle strength and mobility disability in community-dwelling elders. Proc. Am. Thorac. Soc. 6, 581-587 (2009).
125. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: The evidence. CMAJ 174(6), 801-809 (2006).
126. Larson EB. Physical activity for older adults at risk for Alzheimer disease. JAMA 300(9), 1077-1079 (2008).
127. Barak Y, Aizenberg D. Is dementia preventable? Focus on Alzheimer's disease. Expert Rev. Neurother. 10(11), 1689-1698 (2010).
128. Scarmeas N, Luchsinger JA, Schupf N et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 302(6), 627-637 (2009).
129. Lautenschlager NT, Cox KL, Flicker L et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 300(9), 1027-1037 (2008).
130. Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. Resistance training and executive functions: A 12-month randomized controlled trial. Arch. Intern. Med. 170(2), 170-178 (2010).
131. Dechamps A, Diolez P, Thiaudiere E et al. Effects of exercise programs to prevent decline in health-related quality of life in highly deconditioned institutionalized elderly persons: A randomized controlled trial. Arch. Int. Med. 170(2), 162-169 (2010).
132. Etgen T, Sander D, Huntgeburth U, Poppert H, Forstl H, Bickel H. Physical activity and incident cognitive impairment in elderly persons: The INVADE Study. Arch. Int. Med. 170(2), 186-193 (2010).
133. Evans DA, Bienias JL. Alcohol consumption and cognition. N. Engl. J. Med. 352(3), 289-290 (2005). (Pubitemid 40110820)
134. Buchman AS, Boyle PA, Wilson RS, Bienias JL, Bennett DA. Physical activity and motor decline in older persons. Muscle Nerve 35, 354-362 (2007). (Pubitemid 46364091)
135. Buchman AS, Boyle PA, Wilson RS, Fleischman DA, Leurgans S, Bennett DA. Association between late-life social activity and motor decline in older adults. Arch. Int. Med. 169(12), 1139-1146 (2009). Psychosocial factors are known to be related to the rate of cognitive decline. This study found that higher levels of social engagement in older individuals were associated with a slower rate of motor decline. Thus, motor and cognitive decline may share similar risk factors.
136. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 3(6), 343-353 (2004). (Pubitemid 38648855)
137. Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress, age-related neuropathology, and late-life dementia. Psychosom. Med. 69(1), 47-53 (2007). (Pubitemid 46148364)
138. Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, Bennett DA. Proneness to psychological distress and risk of Alzheimer's disease. Neurology 61(11), 1479-1485 (2003). (Pubitemid 37505565)
139. Wilson RS, Krueger KR, Arnold SE et al. Loneliness and risk of Alzheimer disease. Arch. Gen. Psychiatry 64(2), 234-240 (2007). (Pubitemid 46220781)
140. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology 68(24), 2085-2092 (2007). (Pubitemid 46912126)
141. Buchman A, Boyle P, Wilson R et al. Loneliness and the rate of motor decline in old age: The Rush Memory and Aging Project, a community-based cohort study. BMC Geriatrics 10(1), 77 (2010).
142. Rhodes RE, Smith NEI. Personality correlates of physical activity: A review and meta-analysis. Br. J. Sports Med. 40(12), 958-965 (2006). (Pubitemid 44902278)
143. Tolea MI, Costa PT, Terracciano A et al. Sex-specific correlates of walking speed in a wide age-ranged population. J. Gerontol. B Psycholog. Sci. Soc. Sci. 65B(2), 174-184 (2010).
144. Buchman AS, Boyle PA, Leurgans SE, Barnes LL, Bennett DA. Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am. J. Geriatr. Psych. DOI: 10.1097/JGP. 1090b1013e3181ef1097a1092e (2011) (Epub ahead of print).
145. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66(2), 200-208 (2009).
146. Bennett DA, Schneider JA, Arvanitakis Z et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66(12), 1837-1844 (2006). This autopsy study excluded both individuals with MCI and with dementia, yet still found that a substantial proportion (>35%) of cognitively normal adult subjects demonstrated evidence for AD pathology that met pathologic criteria for AD as well as subtle changes in episodic memory. Thus, accumulation of AD pathology in old age may account for cognitive dysfunction currently considered 'normal aging'. (Pubitemid 44049813)
147. Greenberg SA. How citation distortions create unfounded authority: Analysis of a citation network. BMJ 339, b2680 (2009).
148. Salajegheh M, Pinkus JL, Nazareno R, Amato AA, Parker KC, Greenberg SA. Nature of 'Tau' immunoreactivity in normal myonuclei and inclusion body myositis. Muscle Nerve 40(4), 520-528 (2009).
149. Cisek P, Kalaska JF. Neural mechanisms for interacting with a world full of action choices. Ann. Rev. Neurosci. 33(1), 269-298 (2010). Physical frailty, which components includes grip strength, gait speed and BMI, was associated with the level of AD pathology in older persons with and without dementia. This suggests that AD pathology may contribute to loss of motor function in old age.
150. Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 67, 1949-1954 (2006). (Pubitemid 44967369)
151. Buchman AS, Schneider JA, Leurgans S, Bennett DA. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 71(7), 499-504 (2008).
152. Schneider JA, Li JL, Li Y, Wilson RS, Kordower JH, Bennett DA. Substantia nigra tangles are related to gait impairment in older persons. Ann. Neurol. 59(1), 166-173 (2006). (Pubitemid 43042883)
153. Gearing M, Levey AI, Mirra SS. Diffuse plaques in the striatum in Alzheimer disease (AD): Relationship to the striatal mosaic and selected neuropeptide markers. J. Neuropathol. Exp. Neurol. 56(12), 1363-1370 (1997). (Pubitemid 28006582)
154. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS. Progression of regional neuropathology in Alzheimer disease and normal elderly: Findings from the Nun study. Alzheimer Dis. Assoc. Disord. 13(4), 226-231 (1999). (Pubitemid 30011381)
155. Horoupian DS, Wasserstein PH. Alzheimer's disease pathology in motor
156. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 64(8), 1397-1403 (2005). (Pubitemid 40570508)
157. Suva D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J. Primary motor cortex involvement in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58(11), 1125-1134 (1999). (Pubitemid 29519836)
158. Bennett DA, Wilson RS, Schneider JA et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60(12), 1909-1915 (2003). (Pubitemid 36736005)
159. Boyle PA, Wilson RS, Schneider JA, Bienias JL, Bennett DA. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems. Neurology 70(17), 1534-1542 (2008). (Pubitemid 351589507)
160. Rose G. The Strategy of Preventive Medicine. Oxford University Press, Oxford, UK (1992).
161. Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: Mental and physical activity as modulators of brain disorders. Prog. Neurobiol. 89(4), 369-382 (2009).